Related Experiment Video
Updated: Jun 26, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
Invasive Haemophilus influenzae Type B disease in five young children--Minnesota, 2008
Abstract:
In 2008, five children aged <5 years were reported to the Minnesota Department of Health (MDH) with invasive Haemophilus influenzae type b (Hib) disease; one died. Only one of the children had completed the primary Hib immunization series; three had received no doses of Hib-containing vaccine. The five Hib cases are the largest number among children aged <5 years reported from Minnesota since 1992. The cases occurred during a Hib vaccine recall and continuing nationwide shortage that began in December 2007. The recall of certain lots of the two Hib-containing vaccines manufactured by Merck Co., Inc. (West Point, Pennsylvania) and cessation of production of both vaccines left only one manufacturer of Hib vaccine in the United States (Sanofi Pasteur, Swiftwater, Pennsylvania). In response, CDC recommended that health-care providers defer the routine 12--15 month booster dose for children not at increased risk for Hib disease. CDC also emphasized that all children should complete the primary series with available Hib-containing vaccines. However, Minnesota vaccination data indicate that primary Hib series coverage was lower during 2008 than coverage with other vaccines administered at the same ages and lower than Hib coverage in previous years. Increases in Hib cases like the one in Minnesota do not appear to have occurred in other states. The increase highlights the need to ensure that all children complete the primary Hib immunization series. Additional investigation to better elucidate the factors that led to these cases is being conducted by MDH and CDC.
Insights
Five invasive Haemophilus influenzae type b (Hib) cases in young children, including one death, occurred in Minnesota in 2008. This outbreak highlights the critical need for completing the primary Hib immunization series due to vaccine shortages.
Area of Science:
- Pediatric Infectious Diseases
- Vaccinology
- Public Health Surveillance
Background:
- Invasive Haemophilus influenzae type b (Hib) disease poses a significant risk to young children.
- A nationwide recall and shortage of Hib vaccines occurred in late 2007.
- This led to reduced vaccine availability and altered immunization recommendations.
Purpose of the Study:
- To report and analyze an increase in invasive Hib disease cases among children under 5 years old in Minnesota during 2008.
- To investigate the potential impact of vaccine shortages and recall on disease incidence.
- To emphasize the importance of completing the primary Hib immunization series.
Main Methods:
- Retrospective case review of invasive Hib disease reported to the Minnesota Department of Health (MDH).
- Analysis of vaccination status for affected children.
- Comparison of 2008 Hib case numbers with historical data.
- Review of vaccine supply and public health recommendations during the shortage period.
Main Results:
- Five cases of invasive Hib disease were reported in children under 5 years old in Minnesota in 2008, the highest number since 1992.
- Only one of the five children had completed the primary Hib immunization series; three had received no Hib vaccine doses.
- Hib primary series coverage in Minnesota was lower in 2008 compared to previous years and other routine childhood vaccines.
- The increase in cases was associated with a Hib vaccine recall and shortage.
Conclusions:
- The increase in invasive Hib disease cases in Minnesota underscores the critical importance of completing the primary Hib immunization series.
- Vaccine shortages and recalls can have serious public health consequences, leading to decreased vaccination coverage and increased disease incidence.
- Continued surveillance and investigation are necessary to understand factors contributing to such outbreaks and to ensure adequate vaccine supply and uptake.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Influenza
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Streptococcal Pharyngitis